Early phase trials in soft-tissue sarcomas: clinical benefit of inclusion in early lines of treatment, molecular screening, and histology-driven trials - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue ESMO Open Année : 2022

Early phase trials in soft-tissue sarcomas: clinical benefit of inclusion in early lines of treatment, molecular screening, and histology-driven trials

Domaines

Cancer

Dates et versions

hal-04501589 , version 1 (12-03-2024)

Identifiants

Citer

E.F. Nassif, J.-Y. Blay, C. Massard, A. Dufresne, M. Brahmi, et al.. Early phase trials in soft-tissue sarcomas: clinical benefit of inclusion in early lines of treatment, molecular screening, and histology-driven trials. ESMO Open, 2022, 7 (2), pp.100425. ⟨10.1016/j.esmoop.2022.100425⟩. ⟨hal-04501589⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More